Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0088
0.00 (0.00%)
Apr 1, 2025, 3:12 PM EST

Evofem Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
19.3618.2216.848.240.45
Upgrade
Revenue Growth (YoY)
6.29%8.20%104.23%1748.43%-
Upgrade
Cost of Revenue
3.836.514.424.050.47
Upgrade
Gross Profit
15.5311.7112.424.19-0.02
Upgrade
Selling, General & Admin
20.7426.7471.72138.3686.97
Upgrade
Research & Development
1.842.8124.8232.6316.64
Upgrade
Operating Expenses
23.2129.5596.55170.99103.6
Upgrade
Operating Income
-7.68-17.85-84.12-166.8-103.62
Upgrade
Interest Expense
-2.58-2.63-2.09-4.73-2.08
Upgrade
Interest & Investment Income
0.020.030.090.020.17
Upgrade
Other Non Operating Income (Expenses)
0.4-1.933.96-33.66-36.77
Upgrade
EBT Excluding Unusual Items
-9.84-22.34-52.17-205.18-142.31
Upgrade
Other Unusual Items
0.9875.34-24.49--
Upgrade
Pretax Income
-8.8653-76.65-205.18-142.31
Upgrade
Income Tax Expense
-0.020.040.020
Upgrade
Earnings From Continuing Operations
-8.8652.98-76.7-205.19-142.31
Upgrade
Net Income
-8.8652.98-76.7-205.19-142.31
Upgrade
Preferred Dividends & Other Adjustments
0.112.981.321.05-
Upgrade
Net Income to Common
-8.9750-78.01-206.24-142.31
Upgrade
Shares Outstanding (Basic)
755000
Upgrade
Shares Outstanding (Diluted)
75984000
Upgrade
Shares Change (YoY)
-92.36%211082.03%567.40%94.93%66.94%
Upgrade
EPS (Basic)
-0.1210.36-167.42-2953.95-3973.23
Upgrade
EPS (Diluted)
-0.120.05-167.42-2953.95-3975.00
Upgrade
Free Cash Flow
-3.9-8.97-70.75-149.61-107.08
Upgrade
Free Cash Flow Per Share
-0.05-0.01-151.84-2142.80-2989.73
Upgrade
Gross Margin
80.20%64.25%73.78%50.81%-4.93%
Upgrade
Operating Margin
-39.64%-97.96%-499.64%-2023.30%-23234.08%
Upgrade
Profit Margin
-46.30%274.43%-463.35%-2501.69%-31907.85%
Upgrade
Free Cash Flow Margin
-20.14%-49.25%-420.21%-1814.73%-24009.64%
Upgrade
EBITDA
-7.03-17.37-83.11-165.78-103.32
Upgrade
EBITDA Margin
-36.29%-95.34%---
Upgrade
D&A For EBITDA
0.650.481.021.020.3
Upgrade
EBIT
-7.68-17.85-84.12-166.8-103.62
Upgrade
EBIT Margin
-39.64%-97.96%---
Upgrade
Effective Tax Rate
-0.03%---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.